Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s competition with Novo Nordisk A/S.
www.bloomberg.com
#Lillys #Experimental #Obesity #Pill #Holds #Scrutiny #Trial
Lilly’s Experimental Obesity Pill Holds Up to Scrutiny in Trial
